A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...

In a world where diabetes management is evolving at a rapid pace, the spotlight shines on non-invasive glucose monitors that ...

Apple's attempts to develop a non-invasive glucose monitoring feature for Apple Watch remains "many years away" from debuting ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...

In the past few years, we have seen countless reports about Apple's secret work on creating a non-invasive blood glucose ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had ...

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...